Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruikun Du

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Virologica Sinica|October 29, 2022
Revisiting influenza A virus life cycle from a perspective of genome balanceRuikun Du, Qinghua Cui, Zinuo Chen, et al.
Acta Pharmaceutica Sinica. B|May 18, 2021
SARS-CoV-2 cell entry and targeted antiviral developmentZinuo Chen, Ruikun Du, Jazmin M Galvan Achi, et al.
Antiviral Research|April 19, 2021
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL<sup>pro</sup>Ruikun Du, Laura Cooper, Zinuo Chen, et al.
The Journal of General Virology|January 17, 2015
Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirusRuikun Du, Feifei Yin, Manli Wang, et al.
Cell Insight|February 7, 2024
Development of SARS-CoV-2 entry antiviralsMeiyue Dong, Jazmin M Galvan Achi, Ruikun Du, et al.
International Journal of Molecular Sciences|March 14, 2026
Virtual Screening of Marine Natural Products Targeting the F Protein for Anti-RSV Drug DiscoveryWenqing Liu, Xuran Gu, Ruikun Du, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 2, 2022
Synergy Mechanisms of Rhizoma Paridis Saponins on Non-small Cell Lung Cancer: Segmented Solid Phase Extraction, Bioactivity Screening, and Network PharmacologyChen Liu, Qingyun Ma, Ruikun Du, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 26, 2019
Qualitative and Quantitative Analysis for the Chemical Constituents of <i>Tetrastigma hemsleyanum</i> Diels et Gilg Using Ultra-High Performance Liquid Chromatography/Hybrid Quadrupole-Orbitrap Mass Spectrometry and Preliminary Screening for Anti-Influenza Virus ComponentsFuJuan Ding, JiangTing Liu, RuiKun Du, et al.
Antiviral Research|January 11, 2021
Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutininsRuikun Du, Han Cheng, Qinghua Cui, et al.
Viruses|July 24, 2019
Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing <i>Gaussia</i> LuciferaseLin Wang, Qinghua Cui, Xiujuan Zhao, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Virologica Sinica|October 29, 2022
Revisiting influenza A virus life cycle from a perspective of genome balanceRuikun Du, Qinghua Cui, Zinuo Chen, et al.
Acta Pharmaceutica Sinica. B|May 18, 2021
SARS-CoV-2 cell entry and targeted antiviral developmentZinuo Chen, Ruikun Du, Jazmin M Galvan Achi, et al.
Antiviral Research|April 19, 2021
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL<sup>pro</sup>Ruikun Du, Laura Cooper, Zinuo Chen, et al.
The Journal of General Virology|January 17, 2015
Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirusRuikun Du, Feifei Yin, Manli Wang, et al.
Cell Insight|February 7, 2024
Development of SARS-CoV-2 entry antiviralsMeiyue Dong, Jazmin M Galvan Achi, Ruikun Du, et al.
International Journal of Molecular Sciences|March 14, 2026
Virtual Screening of Marine Natural Products Targeting the F Protein for Anti-RSV Drug DiscoveryWenqing Liu, Xuran Gu, Ruikun Du, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 2, 2022
Synergy Mechanisms of Rhizoma Paridis Saponins on Non-small Cell Lung Cancer: Segmented Solid Phase Extraction, Bioactivity Screening, and Network PharmacologyChen Liu, Qingyun Ma, Ruikun Du, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 26, 2019
Qualitative and Quantitative Analysis for the Chemical Constituents of <i>Tetrastigma hemsleyanum</i> Diels et Gilg Using Ultra-High Performance Liquid Chromatography/Hybrid Quadrupole-Orbitrap Mass Spectrometry and Preliminary Screening for Anti-Influenza Virus ComponentsFuJuan Ding, JiangTing Liu, RuiKun Du, et al.
Antiviral Research|January 11, 2021
Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutininsRuikun Du, Han Cheng, Qinghua Cui, et al.
Viruses|July 24, 2019
Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing <i>Gaussia</i> LuciferaseLin Wang, Qinghua Cui, Xiujuan Zhao, et al.
Pageof 7